Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Pharmaceutical Preparations · Malvern, PA · filing with the SEC since 2010
Who runs Annovis Bio, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Maccecchini Maria-Luisa
President & CEO. First filing Jan 2020, latest Nov 12, 2025, 3 filings in all.
Officers reporting now
1
of 3 people with a filing in the last fifteen months
Directors reporting now
2
9 people on the record since 2020
Officerssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Maccecchini Maria-Luisa | President & CEO | Jan 2020 | Nov 12, 2025 | none |
Directorssales are open-market, Nov 6, 2025 to Nov 6, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Hoffman Michael B | director | Jan 2020 | Nov 6, 2026 | none |
| Bruck Claudine | director | Jan 2020 | Nov 12, 2025 | none |
Earlier names on the record6, newest filing first
Walsh Andrew · officer · last filing Jun 2025Mccarthy Reid · director · last filing Jun 2025White Mark K. · director · last filing Jul 2024Hagopian Henry III · officer · last filing Nov 2023Mcgroarty Jeffrey Brian · officer · last filing Jan 2022Whelan, Jr. Robert M. · director · last filing Jul 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.